tanshinone has been researched along with Angiogenesis, Pathologic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Li, X; Lu, Y; Qian, C; Wan, X; Wang, A; Wei, Z; Wu, Y; Zhang, S; Zhao, Y; Zou, W | 1 |
| Wang, X; Wu, C | 1 |
| Feng, Y; Fu, J; Ji, Q; Jia, R; Li, Q; Li, Y; Liu, N; Sui, H; Wang, T; Wang, Y; Zhang, B; Zhang, Z; Zhou, L | 1 |
| Chang, J; Duan, Y; Hou, G; Huang, H; Qin, J; Song, C; Yao, Y; Zhang, Y; Zhao, C | 1 |
| Cai, J; Chai, N; Deng, W; Feng, Y; Ji, Q; Li, C; Li, Q; Liu, X; Sui, H; Wen, H; Zhang, Q; Zhao, J; Zhou, L | 1 |
| Chen, Y; Cui, H; Gao, N; Hu, X; Li, G; Liu, L; Shan, C; Zhou, J; Zhou, T | 1 |
| Li, JX; Miao, ZH; Wang, Y; Wang, YQ | 1 |
| Abdolmaleky, HM; Gong, Y; Li, L; Li, Y; Zhou, JR | 1 |
| Ci, SJ; Hu, Q; Li, Q; Liu, NN; Liu, X; Qin, JM; Sui, H; Wang, Y; Yin, PH; Zhou, LH | 1 |
| Jiang, C; Jiang, P; Kim, SH; Lü, J; Ye, M; Zhang, Y | 1 |
1 review(s) available for tanshinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Tanshinones: sources, pharmacokinetics and anti-cancer activities.
Topics: Abietanes; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Humans; Neoplasms; Neovascularization, Pathologic; Salvia miltiorrhiza | 2012 |
9 other study(ies) available for tanshinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Topics: Abietanes; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation; Humans; Ischemia; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Receptor, TIE-2; Tumor Cells, Cultured; Vesicular Transport Proteins; Xenograft Model Antitumor Assays | 2021 |
Tanshinone IIA improves cardiac function via regulating miR-499-5p dependent angiogenesis in myocardial ischemic mice.
Topics: Abietanes; Animals; Cardiovascular Agents; Disease Models, Animal; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Neovascularization, Pathologic; Neovascularization, Physiologic; PTEN Phosphohydrolase | 2022 |
Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
Topics: Abietanes; Angiogenesis Inducing Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Signal Transduction; Tumor Hypoxia; Vascular Endothelial Growth Factor A | 2020 |
Design, synthesis and biological evaluation of tanshinone IIA-based analogues: Potent inhibitors of microtubule formation and angiogenesis.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Microtubules; Molecular Structure; Neovascularization, Pathologic; Structure-Activity Relationship; Tumor Cells, Cultured; Zebrafish | 2021 |
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Topics: Abietanes; Angiogenesis Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; beta Catenin; Cell Movement; Cell Proliferation; Chick Embryo; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fibroblast Growth Factor 2; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphoid Enhancer-Binding Factor 1; Male; Mice, Nude; Middle Aged; Neovascularization, Pathologic; Neovascularization, Physiologic; Ribonuclease, Pancreatic; Signal Transduction; Transfection; Transforming Growth Factor beta1; Tumor Burden; Tumor Hypoxia; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
Topics: Abietanes; Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasm Proteins; Neovascularization, Pathologic; Phosphoproteins; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2015 |
Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aurora Kinase A; Aurora Kinases; Blotting, Western; Body Weight; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, SCID; Neovascularization, Pathologic; Protein Serine-Threonine Kinases; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
Tanshinone II--a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Promoter Regions, Genetic; RNA, Messenger; Statistics, Nonparametric; Transcription, Genetic; Transfection; Vascular Endothelial Growth Factor A | 2012 |